Ketoprofen is a medication used to help manage symptoms associated with various painful and inflammatory conditions. It is indicated for the symptomatic relief of acute mild to moderate pain, which commonly includes discomfort following minor injuries, dental procedures, and short-term muscular strain. The medication may also be used to address pain and stiffness related to chronic conditions such as rheumatoid arthritis and osteoarthritis.

The primary benefit for the patient is to help alleviate pain and reduce inflammation, which can support improved mobility and function during daily activities. The goal of using Ketoprofen is symptomatic relief, not to modify the underlying disease. Patients should consult a healthcare professional to understand the approved uses for this medication and to determine if it is appropriate for their specific needs.

Quick Fact: Symptomatic Relief

Ketoprofen may be an option for addressing pain and inflammation in joints, muscles, and soft tissues for approved conditions. Official therapeutic guidance provides details on specific approved indications for use.

Eligibility and Contraindications

Official regulatory documents define strict criteria regarding which populations can or cannot use Ketoprofen, based primarily on pre-existing medical conditions, age, and physiological status.

Classification	Population or Condition
Absolute Contraindication	Known hypersensitivity to Ketoprofen, aspirin, or other NSAIDs.
Absolute Contraindication	Active or history of recurrent peptic ulcer, gastrointestinal bleeding, or perforation.
Absolute Contraindication	Severe renal, severe hepatic, or severe uncontrolled heart failure.
Absolute Contraindication	Perioperative pain treatment in the setting of Coronary Artery Bypass Graft (CABG) surgery.
Absolute Contraindication	The third trimester of pregnancy (from 20 weeks gestation onward, as per FDA warnings).
Use Not Established	Pediatric patients below the age of 18 years (US labeling) or children under 15 years (European labeling).
Restricted Use	Older-adult (geriatric) patients, who require close monitoring due to increased risk of serious adverse events.
Restricted Use	Patients with pre-existing mild to moderate cardiovascular conditions (e.g., mild heart failure, uncontrolled hypertension) or mild organ impairment.
Not Recommended	Women who are breastfeeding or attempting to conceive.

These eligibility rules reflect the standardized regulatory classifications used to define necessary population constraints for this class of medicine, specifically limiting use to adults and adolescents over 15 who do not present the listed high-risk comorbidities or physiological states.

Interactions with other medicines and products

The official regulatory documents specify several clinically significant interaction patterns for Ketoprofen.

Contraindicated and Restricted Combinations Co-administration is contraindicated for treating perioperative pain in the setting of coronary artery bypass graft (CABG) surgery. The combination with other NSAIDs, including high-dose salicylates, is officially avoided due to an increased risk of gastrointestinal ulceration and hemorrhage. Co-administration with Probenecid is not recommended because it significantly reduces Ketoprofen plasma clearance, which increases drug exposure.

Interactions Affecting Exposure and Toxicity Ketoprofen is documented to elevate the plasma levels and increase the toxicity of Lithium and high-dose Methotrexate. A mandatory timing rule requires that Methotrexate must not be administered less than 12 hours before or after Ketoprofen treatment. Conversely, co-administration with Aspirin is documented to increase Ketoprofen's plasma clearance.

Pharmacodynamic Risk Reinforcement Ketoprofen shows combined risks when taken with other agents. This includes an increased risk of bleeding with Oral Anticoagulants, Antiplatelet Agents, Oral Corticosteroids, and SSRIs. Concomitant use with Diuretics, ACE Inhibitors, or ARBs may diminish their therapeutic effect and is associated with an increased risk of nephrotoxicity and renal failure, especially in the elderly or those with impaired renal function.

Substance and Food Interactions The official labeling notes that Alcohol may increase the risk of gastrointestinal blood loss. While Food reduces the peak plasma concentration (Cmax) of Ketoprofen, Antacids (aluminum/magnesium hydroxide) do not interfere with the rate or extent of its absorption.

The functional characteristics of Ketoprofen are defined by its ability to interfere with key enzyme systems involved in inflammatory and pain-signaling pathways at the molecular level. This intervention modulates physiological processes through targeted enzyme inhibition, determining the functional characteristics of the molecule.

Molecular Blockade of Prostaglandin Synthesis

Ketoprofen acts by establishing non-selective competitive inhibition of the Cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. By blocking the active sites of these enzymes, the drug suppresses the metabolic conversion of arachidonic acid into pro-inflammatory mediators and prostaglandins.

Modulation of Nociceptive and Central Thermoregulatory Systems

The resulting reduction in prostaglandin E2 (PGE2) levels influences multiple systems. Peripherally, this reduction decreases the responsiveness of nociceptors (pain-sensing nerves) at the site of tissue changes. Centrally, this mechanistic domain affects the hypothalamus, leading to a downward adjustment of the elevated thermoregulatory set-point.

Ketoprofen administration follows standardized usage principles to ensure consistent application across its different formulations. The primary approved methods of delivery are the oral route, encompassing immediate-release (IR) capsules, extended-release (ER) capsules, and oral granules, and the topical route, primarily using gels for cutaneous application.

The required dosing schedule depends directly on the chosen formulation. Immediate-release oral capsules are typically administered in divided doses, such as 50 mg four times a day or 75 mg three times a day, with a maximum limit of 300 mg per day for adult systemic use. In contrast, the extended-release 200 mg capsule is specifically designed for a simpler once-daily regimen and is generally not used for acute pain episodes.

In terms of administration, oral doses may be consumed with food, milk, or an antacid to help mitigate potential gastrointestinal discomfort. Established protocols also include dose modifications for specific patient populations. For instance, lower initial doses are required for older adults, and maximum daily doses are reduced for patients with renal or hepatic impairment. Topical usage is strictly limited to external application on the skin and must not be applied to open wounds or under occlusive dressings. These guidelines collectively establish the method for the use of ketoprofen.

Research on Short-Term and Localized Conditions

Ketoprofen has been extensively studied in Randomized Controlled Trials (RCTs) and Systematic Reviews focused on outcomes related to physical discomfort experienced by adult populations. This research examined its application in patient groups experiencing acute episodes, such as cohorts following minor surgical procedures or trauma. Studies monitored measurements of pain intensity changes and the assessed rate of change in discomfort over short time intervals. Findings describe consistent patterns observed in these measurements when compared to controls.

Research also explored oral versus topical preparations (like gels) for localized conditions, such as minor sports injuries. Controlled trials monitored localized outcomes related to physical discomfort, including pain felt upon touch and changes in joint movement.

---

Evidence for Chronic and Sustained Use

Research has explored the use of Ketoprofen in chronic conditions characterized by functional limitations, such as rheumatoid arthritis (RA) and osteoarthritis (OA). Studies primarily involved adult populations, including older adults, and monitored outcomes reflecting daily functioning or activity level over several weeks or months. The majority of evidence available has involved study designs that use other medicines in the same class as comparators. Long-term outcomes are not fully established, and limited information is available regarding the sustained observation of the measured patterns over multiple years of use.

---

Study Limitations and Special Populations

Several research limitations are noted in the broader evidence landscape. One primary limitation is that follow-up durations were limited in many core efficacy trials for acute conditions. Findings describe the monitoring of age-related changes in older adults, where patterns associated with a reduced renal clearance of the medicine’s metabolite were observed. For the pediatric population (children under 18), comprehensive research on the evidence base is not widely documented for general indications, and broader data are still emerging.

Common questions about Ketoprofen (FAQ)

---

Q: How quickly does Ketoprofen typically start working?

Studies and official product information indicate that the analgesic effect of immediate-release Ketoprofen can begin in as little as one hour. The highest concentration in the bloodstream is typically reached between half an hour and two hours after taking the capsule. This timeframe reflects when the medicine is working most actively in the body.

---

Q: How long does the effect of one dose of Ketoprofen last?

The elimination half-life, which is the time it takes for half of the medicine to be removed from the body, is approximately 2 to 4 hours. This duration is consistent with how the drug is typically administered, which can be every 6 to 8 hours.

---

Q: Do you need a prescription for Ketoprofen in some countries?

Regulatory documents describe Ketoprofen as a medicine that is usually obtained via prescription from a healthcare provider. However, official reviews note that some lower-strength formulations are available over-the-counter (OTC) without a prescription in certain regions, particularly in Europe.

---

Q: Can Ketoprofen cause sleepiness or drowsiness?

Official labeling lists potential adverse reactions for Ketoprofen, which include central nervous system effects such as somnolence (drowsiness) and dizziness. These reactions are reported in a small percentage of users (1% to 10%). Official documents include warnings that the medicine may cause these effects.

---

Q: Is Ketoprofen commonly used for conditions like arthritis?

Official prescribing information indicates that Ketoprofen is used for treating the signs and symptoms of inflammatory conditions. This includes both rheumatoid arthritis (RA) and osteoarthritis (OA).

---

Q: What is the reported duration of Ketoprofen treatment in clinical studies?

Clinical trials for acute pain conditions, such as those following minor surgical procedures, have examined the use of Ketoprofen for durations of up to three weeks. For chronic conditions like arthritis, the drug is studied for longer periods, often requiring continuous medical monitoring.

---

Q: Is it true that Ketoprofen can increase sun sensitivity?

Yes, official regulatory reviews, especially concerning topical (skin) forms of Ketoprofen, have noted reports of photoallergy. This means the medicine may cause an allergic reaction in the skin when exposed to sunlight. Warnings advise users to protect the skin from sun exposure.

---

Q: What is the documented half-life of Ketoprofen?

The documented elimination half-life for immediate-release oral Ketoprofen is approximately 2 to 4 hours in adults. This is a measure of how quickly the body processes and eliminates the substance.

---

Q: What is the official advice regarding Ketoprofen and breastfeeding?

While the transfer of Ketoprofen into breast milk is described as low, official documents note that adverse effects have been observed in breastfed infants. For this reason, official documents describe the use of alternative agents as a consideration, particularly when nursing a newborn.

---

Q: What is the main difference between Ketoprofen and Ibuprofen?

Both Ketoprofen and Ibuprofen belong to the same pharmacological category: non-steroidal anti-inflammatory drugs (NSAIDs) of the propionic acid class. Both are defined in regulatory documents as distinct medicinal entities within the same class.

---

Q: Can Ketoprofen be used for treating general muscle soreness?

Official regulatory indications for Ketoprofen include the treatment of signs and symptoms related to pain and inflammation. This generally covers conditions such as musculoskeletal strain and muscle pain.

---

Q: Is Ketoprofen described as a strong pain reliever?

The drug is classified as an agent with analgesic (pain-relieving) properties. However, summaries of clinical trials often note that increasing the dose above a certain threshold is not likely to provide better pain relief.

---

Q: Can Ketoprofen be used for headaches or migraines?

Ketoprofen is officially indicated for general pain and inflammation. Clinical research has investigated its effectiveness for the acute treatment of episodic tension-type headaches in adults, with findings noted in research reviews.

---

Q: Is there any research on Ketoprofen use in children?

Regulatory documents indicate that the general use of Ketoprofen in the pediatric population (under 18) is typically not established. However, research has been conducted and documented for specific conditions, such as juvenile rheumatoid arthritis and for post-surgical pain management.

---

Q: Does Ketoprofen have potential for dependency or addiction?

Ketoprofen is an NSAID and is classified by relevant agencies as a substance that is not controlled. This classification means it has no recognized potential for physical dependency or addiction.

---

Q: How is Ketoprofen typically removed from the body?

Official clinical pharmacology information states that Ketoprofen is processed by the liver through a metabolic pathway called glucuronide conjugation. The majority of the medicine, up to 90%, is then excreted from the body through the urine within 24 hours.

---

Q: Is there an official list of contraindications for Ketoprofen?

Yes, official prescribing information documents contain a dedicated section that lists the conditions and situations where the medicine must not be used. This list, often titled 'Contraindications,' is defined by regulatory agencies.

---

Q: Does Ketoprofen have different brand names I should be aware of?

Yes, Ketoprofen is the active ingredient, which is sold globally under multiple different brand names. Examples listed in authoritative drug indices include Orudis and Oruvail.

---

Q: Can Ketoprofen be used to reduce fever?

Ketoprofen is classified as having an antipyretic effect, which means it can lower fever. In veterinary medicine, the injectable form is officially indicated for the control of fever associated with bovine respiratory disease.

---

Q: Are there any documented interactions between Ketoprofen and common cold medicines?

Official interaction sections caution against the combined use of Ketoprofen with other non-steroidal anti-inflammatory drugs (NSAIDs). Since many common cold and flu remedies contain NSAIDs, taking these together is noted to increase the risk of gastrointestinal adverse events.

---

Q: What are the major limitations of the clinical studies on Ketoprofen?

Research summaries note several limitations, including that many core efficacy trials for acute conditions had limited follow-up durations. Furthermore, long-term outcomes, particularly for sustained use in chronic conditions, are not fully established in the available evidence base.

---

Q: Is Ketoprofen used in veterinary medicine for animals?

Yes, Ketoprofen is used in veterinary medicine. For example, the injectable form is officially indicated for use in cattle to control fever.

---

Q: Are there reasons why people with asthma should not use Ketoprofen?

Regulatory information contraindicates the use of Ketoprofen in patients with a history of asthma, hives (urticaria), or allergic reactions after taking aspirin or other NSAIDs. This is due to the potential risk of severe bronchospasm (sudden airway narrowing).

How to Store and Dispose of Ketoprofen

Ketoprofen must be stored at Controlled Room Temperature, which is between 20 C and 25 C (68 F and 77 F). The medication must be kept in a tight, light-resistant container and protected from moisture and excessive heat.

Storage and Protection Rules

• Do not freeze the product.
• Keep the container tightly closed and store the medicine out of the reach of children.

Disposal

Expired or unused Ketoprofen should be disposed of via a drug take-back program when available. If a program is not accessible, the product may be mixed with an unappealing substance, sealed in a bag, and thrown into the household trash. The medication should not be flushed down a toilet or drain.